Form 4 for BVS Bioventus Inc.
Accepted 2023-04-05 00:00:00 ET · period of report 2023-04-03 · accession 0001578563-23-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-05 | 2023-04-03 | BVS | CHURCH KATRINA J | SVP, CCO | S - Sale | $1.07 | -117 | 10.4K | -1% | -$125.19 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-04-03 | S | D | 117 | $1.07 | 10,353 | D | — | — | (F2) Includes 5,846 shares of Class A common stock purchased under the Company's 2021 Employee Stock Purchase Plan. |